Haibing He

2.0k total citations
89 papers, 1.7k citations indexed

About

Haibing He is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Biology. According to data from OpenAlex, Haibing He has authored 89 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Pharmaceutical Science, 33 papers in Biomaterials and 25 papers in Molecular Biology. Recurrent topics in Haibing He's work include Drug Solubulity and Delivery Systems (45 papers), Advanced Drug Delivery Systems (42 papers) and Nanoparticle-Based Drug Delivery (30 papers). Haibing He is often cited by papers focused on Drug Solubulity and Delivery Systems (45 papers), Advanced Drug Delivery Systems (42 papers) and Nanoparticle-Based Drug Delivery (30 papers). Haibing He collaborates with scholars based in China, Egypt and Norway. Haibing He's co-authors include Xing Tang, Tian Yin, Jingxin Gou, Yu Zhang, Xing Tang, Rui Yang, Yanjiao Wang, Cuifang Cai, Xiaoguang Tao and Jijun Fu and has published in prestigious journals such as Journal of Controlled Release, Nanoscale and Acta Biomaterialia.

In The Last Decade

Haibing He

82 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haibing He China 24 884 435 433 258 215 89 1.7k
İmran Vural Türkiye 28 831 0.9× 619 1.4× 543 1.3× 263 1.0× 111 0.5× 77 1.9k
Ghareb M. Soliman Egypt 26 705 0.8× 561 1.3× 458 1.1× 252 1.0× 267 1.2× 57 2.0k
Aifeng Zou China 7 843 1.0× 547 1.3× 323 0.7× 248 1.0× 184 0.9× 9 1.7k
Omer Mustapha Pakistan 16 730 0.8× 683 1.6× 478 1.1× 477 1.8× 246 1.1× 25 1.9k
Asim Ur Rehman Pakistan 16 530 0.6× 392 0.9× 289 0.7× 297 1.2× 112 0.5× 43 1.4k
Bo Tang China 20 673 0.8× 337 0.8× 329 0.8× 181 0.7× 199 0.9× 36 1.3k
Bader M. Aljaeid Saudi Arabia 17 528 0.6× 453 1.0× 352 0.8× 301 1.2× 173 0.8× 27 1.4k
Yanjiao Wang China 28 483 0.5× 323 0.7× 451 1.0× 244 0.9× 239 1.1× 103 1.8k
Riyaz Ali M. Osmani India 24 653 0.7× 533 1.2× 387 0.9× 419 1.6× 167 0.8× 117 1.8k
Yıldız Özsoy Türkiye 24 862 1.0× 363 0.8× 325 0.8× 217 0.8× 94 0.4× 82 1.8k

Countries citing papers authored by Haibing He

Since Specialization
Citations

This map shows the geographic impact of Haibing He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haibing He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haibing He more than expected).

Fields of papers citing papers by Haibing He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haibing He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haibing He. The network helps show where Haibing He may publish in the future.

Co-authorship network of co-authors of Haibing He

This figure shows the co-authorship network connecting the top 25 collaborators of Haibing He. A scholar is included among the top collaborators of Haibing He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haibing He. Haibing He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeng, Chun, Chenxiao Chu, Boyuan Liu, et al.. (2025). pH-responsive ZIF-8 nanoplatform co-loaded with DSF and ICG for multiple synergistic antitumor therapy. International Journal of Pharmaceutics. 672. 125343–125343. 2 indexed citations
2.
Pan, Shu, Yibo Wang, Yu Zhang, et al.. (2025). Linoleic acid co-administration promotes oral delivery of exenatide-loaded butyrate-decorated nanocapsules. Journal of Controlled Release. 382. 113744–113744. 1 indexed citations
3.
Liu, Hongbing, Xinxin Liang, Mingli Wei, et al.. (2025). Harnessing macrophages for precision drug delivery and cancer therapy: Strategies, advances and challenges. Materials Today Bio. 35. 102535–102535. 2 indexed citations
4.
Chu, Chenxiao, Mingli Wei, Yuying Wang, et al.. (2025). Precision-targeted explosion of biomimetic nanoparticles for the effective treatment of uveal melanoma. International Journal of Pharmaceutics. 675. 125543–125543. 1 indexed citations
6.
7.
Deng, Yaxin, et al.. (2024). Long-acting bulleyaconitine A microspheres via intra-articular delivery for multidimensional therapy of rheumatoid arthritis. International Journal of Pharmaceutics. 661. 124414–124414.
8.
Sun, Shiqi, Meihui Zhao, Yu Zhang, et al.. (2023). Preparation and pharmacokinetics study of albumin-coated crystalline progesterone long-acting microcapsules for injection. Journal of Drug Delivery Science and Technology. 88. 104905–104905.
9.
Guo, Chen, Haoyang Yuan, Ying Yu, et al.. (2023). FRET-based analysis on the structural stability of polymeric micelles: Another key attribute beyond PEG coverage and particle size affecting the blood clearance. Journal of Controlled Release. 360. 734–746. 23 indexed citations
10.
Wang, Jiahui, Hongbing Liu, Yanjiao Wang, et al.. (2022). The effect of granules characters on mechanical properties of press-coated tablets: A comparative study. International Journal of Pharmaceutics. 624. 121986–121986. 10 indexed citations
11.
Zhao, Meihui, Jiaojiao Yin, Tian Yin, et al.. (2021). Quaternary enteric solid dispersion prepared by hot-melt extrusion to mask the bitter taste and enhance drug stability. International Journal of Pharmaceutics. 597. 120279–120279. 9 indexed citations
12.
Zhang, Ying, Yi Liu, Na Wang, et al.. (2021). Preparation of mPEG-b-PLA/TM-2 Micelle Lyophilized Products by Mixed Lyoprotectors and Antitumor Effect In Vivo. AAPS PharmSciTech. 22(1). 38–38. 5 indexed citations
13.
Cai, Qing, Luying He, Wei Chu, et al.. (2018). Process control and in vitro/in vivo evaluation of aripiprazole sustained-release microcrystals for intramuscular injection. European Journal of Pharmaceutical Sciences. 125. 193–204. 12 indexed citations
14.
Chao, Yanhui, Guihua Fang, Haibing He, et al.. (2016). Biodegradable Polymersomes as Nanocarriers for Doxorubicin Hydrochloride: Enhanced Cytotoxicity in MCF-7/ADR Cells and Prolonged Blood Circulation. Pharmaceutical Research. 34(3). 610–618. 19 indexed citations
15.
Li, Xin, et al.. (2016). Influence of lipid composition on the oral bioavailability of cinnarizine sub‐microemulsions. European Journal of Lipid Science and Technology. 119(3). 4 indexed citations
16.
Tan, Xinyi, Yue Zhong, Luying He, et al.. (2016). Morphological and Crystalline Transitions in Monohydrous and Anhydrous Aripiprazole for a Long-Acting Injectable Suspension. AAPS PharmSciTech. 18(4). 1270–1276. 10 indexed citations
17.
He, Haibing, Bo Shi, Cuifang Cai, & Xing Tang. (2011). Preparation of lovastatin matrix sustained-release pellets by extrusion-spheronization combined with microcrystal dispersion technique. Archives of Pharmacal Research. 34(11). 1931–1938. 3 indexed citations
18.
Li, Guofei, et al.. (2010). Isosorbide-5-mononitrate (5-ISMN) sustained-release pellets prepared by double layer coating for reducing 5-ISMN migration and sublimation. International Journal of Pharmaceutics. 400(1-2). 138–144. 7 indexed citations
19.
Lü, Yan, et al.. (2008). Preparation and Bioavailability of Sustained-Release Doxofylline Pellets in Beagle Dogs. Drug Development and Industrial Pharmacy. 34(7). 676–682. 5 indexed citations
20.
He, Haibing. (2006). Research overviews of multivesicular liposomes. Zhongguo xin yao zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026